Now Playing
|Videos|August 26, 2021
Role of First Generation FLT3 Inhibitors in AML
Expert discusses the role of FLT3 inhibitors in the treatment of AML and if benefit from midostaurin in combination with chemotherapy can be predicted.
Advertisement
Episodes in this series
Advertisement
Related to this article
In an interview with Pharmacy Times, City of Hope researchers discuss a preclinical platform designed to redirect CAR T cells after infusion and how pharmacists could help bring this adaptable approach into clinical practice.
Advertisement
Advertisement
Trending on Pharmacy Times
1
VYD2311 May Offer Vaccine-Hesitant and Immunocompromised Individuals a New COVID-19 Immunization Option
2
National Pharmacy Technician Day: Celebrating the Backbone of Pharmacy
3
Cemdisiran’s Potential to Reduce Hospitalizations in Myasthenia Gravis
4
Supporting Patients Prescribed Opioids in the Era of “Fentanyl Free America”
5